Hiroyuki Takeda, Kumiko Umemoto, Ryoji Takada, Tomoyuki Satake, Shunsuke Onoe, Satoshi Shimizu, Hiroshi Nakase, Kenro Hirata, Kazuhiko Shioji, Kazuyuki Matsumoto, Ayako Hata, Kenichiro Tanabe, Makoto Ueno, Junji Furuse, Yu Sunakawa. "A phase II study of re-introduction of gemcitabine plus cisplatin in combination with durvalumab after durvalumab maintenance therapy in patients with unresectable or recurrent biliary tract cancer (PRIDE study).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps609